| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 119.08B | 115.11B | 111.97B | 114.20B | 107.61B |
| Gross Profit | 29.30B | 70.37B | 25.21B | 18.88B | 16.43B |
| EBITDA | 50.76B | 53.74B | 44.52B | 43.08B | 38.95B |
| Net Income | 9.61B | 11.21B | 17.79B | 8.00B | 4.18B |
Balance Sheet | |||||
| Total Assets | 310.83B | 328.29B | 313.44B | 321.03B | 299.47B |
| Cash, Cash Equivalents and Short-Term Investments | 7.83B | 8.48B | 7.28B | 5.77B | 7.62B |
| Total Debt | 141.18B | 146.46B | 140.82B | 147.16B | 142.07B |
| Total Liabilities | 218.60B | 229.65B | 222.21B | 233.71B | 218.00B |
| Stockholders Equity | 62.17B | 63.30B | 56.92B | 48.56B | 42.68B |
Cash Flow | |||||
| Free Cash Flow | 28.31B | 20.70B | 19.43B | 11.71B | 5.81B |
| Operating Cash Flow | 40.63B | 39.87B | 37.30B | 35.82B | 32.17B |
| Investing Cash Flow | -32.01B | -18.90B | -22.91B | -22.31B | -27.40B |
| Financing Cash Flow | -8.07B | -20.28B | -12.83B | -15.44B | -10.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | €3.20B | 12.76 | 18.18% | 6.73% | -0.62% | 16.87% | |
71 Outperform | €5.75B | 5.42 | 8.76% | 6.31% | 2.77% | -31.49% | |
67 Neutral | €163.01B | 14.02 | 20.18% | 3.28% | 3.58% | 103.26% | |
64 Neutral | €4.02B | 24.55 | 2.07% | 0.21% | -0.46% | -50.77% | |
62 Neutral | €4.92B | 24.89 | 2.80% | 7.04% | -2.19% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |